CRISPR-edited immune cells can survive and thrive after infusion into cancer patients February 6, 2020 adminMeds newsNo Comment on CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Genetically edited immune cells can persist, thrive, and function months after a cancer patient receives them.